Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Neurological disorders in hypertensive patients

https://doi.org/10.14412/2074-2711-2015-4-57-64

Full Text:

Abstract

Hypertension is one of the most common vascular diseases. The brain as target organs in hypertension is damaged more often and earlier. Neurological complications due to hypertension are frequently hyperdiagnosed in Russian neurological practice. Thus, headache, dizziness, impaired recall of recent events, nocturnal sleep disorders, and many other complaints in a hypertensive patient are usually regarded as a manifestation of dyscirculatory encephalopathy. At the same time headaches (tension headache and migraine) in hypertensive patients are predominantly primary; headache associated with dramatic marked elevations in blood pressure is encountered in only a small number of patients. The role of cerebrovascular diseases in the development of dizziness in hypertensive patients is also overestimated. The vast majority of cases, patients with this complaint are in fact identified to have benign paroxysmal postural vertigo, Mеniеre’s disease, vestibular neuronitis, or vestibular migraine. Psychogenic disorders or multisensory insufficiency are generally responsible for non-systemic vertigo in hypertensive patients. Chronic cerebral circulatory insufficiency may cause non-systemic vertigo as a subjective equivalent of postural instability.

Cognitive impairments (CIs) are the most common and earliest manifestation of cerebrovascular lesion in hypertension. In most cases, CIs in hypertension were vascular and associated with cerebrovascular lesion due to lacunar infarcts and leukoaraiosis. However, mixed CIs frequently occur when hypertensive patients are also found to have signs of a degenerative disease, most commonly in Alzheimer’s disease.

About the Authors

N. V. Vakhnina
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation

Department of Nervous System Diseases and Neurosurgery,

11, Rossolimo St., Moscow 119021



O. V. Milovanova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation

Department of Nervous System Diseases and Neurosurgery,

11, Rossolimo St., Moscow 119021



V. V. Grinyuk
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation

Department of Nervous System Diseases and Neurosurgery,

11, Rossolimo St., Moscow 119021



References

1. Чазов ЕИ, Вихерт АМ, Оганов РГ. В кн. Академия Медицинских Наук СССР. Сессия общего собрания 51-я. Тезисы докладов. Москва; 1984. С. 4-8. [Chazov EI, Vikhert AM, Oganov RG. In: Akademiya Meditsinskikh Nauk SSSR. Sessiya obshchego sobraniya 51-ya. Tezisy dokladov [Academy of Medical Sciences of the USSR. 51st Session of the General Assembly. Abstracts]. Moscow; 1984. P. 4-8.]

2. Парфенов ВА, Алексеев ВВ, Шварева НС, Рыжак АА. Головная боль у больных артериальной гипертонией. Клиническая геронтология. 2001;6(5):3-9. [Parfenov VA, Alekseev VV, Shvareva NS, Ryzhak AA. Headache in patients with arterial hypertension. Klinicheskaya gerontologiya. 2001;6(5):3-9. (In Russ.)].

3. Classification and Diagnostic Criteria for Headache Disorders Cranial Neuralgia and facial Pain. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988;8 Suppl 7:1-96.

4. Weiss NS. Relation of high blood pressure to headache episiaxis and seleced other symptoms. N Engl J Med. 1972 Sep 28;287(13):631-3.

5. Russmussen BK, Jensen R, Shroll M, Olsen J. Epidemiology of a general population – a prevalence study. J Clin Epidemiol. 1991;44(11):1147-57.

6. Парфенов ВА, Неверовский ДВ. Ведение пациентов с дисциркуляторной энцефалопатией в амбулаторной практике. Неврология, нейропсихиатрия, психосоматика. 2015;7(1):37–42. [Parfenov VA, Neverovskii DV. Outpatient management of patients with dyscirculatory encephalopathy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, neuropsychiatry, psychosomatics. 2015;7(1):37–42. (In Russ.)]. DOI: http://dx.doi.org/10.14412/2074-2711-2015-1-37-42

7. Толмачева ВА. Причины головокружения. Неврология, нейропсихиатрия, психосоматика. 2010;2(4):18-23. [Tolmacheva VA. Causes of vertigo. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, neuropsychiatry, psychosomatics. 2010;2(4):18-23. (In Russ.)]. DOI: http://dx.doi.org/10.14412/2074-2711-2010-111

8. Замерград МВ. Головокружение у пациентов с диагнозом дисциркуляторной энцефалопатии. Медицинский совет. 2014;(5):22-6. [Zamergrad MV. Dizziness in patients with dyscirculatory encephalopathy. Meditsinskii sovet. 2014;(5):22-6. (In Russ.)].

9. Brandt T, Bronstein AM. Cervical vertigo. J Neurol Neurosurg Psychiatry. 2001 Jul;71(1):8-12.

10. Парфенов ВА, Замерград МВ, Мельников ОА. Головокружение: диагностика и лечение, распространенные диагностические ошибки. Москва: МИА; 2009. 152 С. [Parfenov VA, Zamergrad MV, Mel'nikov OA. Golovokruzhenie: diagnostika i lechenie, rasprostranennye diagnosticheskie oshibki [Dizziness: diagnosis and treatment, common diagnostic errors]. Moscow: MIA; 2009. 152 P.]

11. Толмачева ВА, Парфенов ВА. Причины головокружения у пациентов с артериальной гипертензией и его лечение. Врач. 2007;(4):49-53. [Tolmacheva VA, Parfenov VA. Causes of dizziness in patients with arterial hypertension and its treatment. Vrach. 2007;(4):49-53. (In Russ.)].

12. Смулевич АБ. Психокардиология и основные аспекты психосоматической медицины. Психиатрия и психофармакотерапия. 2005;7(3):6-9. [Smulevich AB. Psychocardiology and the main aspects of psychosomatic medicine. Psikhiatriya i psikhofarmakoterapiya. 2005;7(3):6-9. (In Russ.)].

13. Rosengren A, Hauken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTER-HEART study): case-control study. Lancet. 2004 Sep 11-17;364(9438):953-62.

14. Юдина НВ, Ишутина НП, Раева ТВ. Психические расстройства на начальных стадиях эссенциальной артериальной гипертензии. Медицинская наука и образование Урала. 2009;(1):70-3. [Yudina NV, Ishutina NP, Raeva TV. Mental disorders in the initial stages of essential arterial hypertension. Meditsinskaya nauka i obrazovanie Urala. 2009;(1):70-3. (In Russ.)].

15. Смулевич АБ. Лекции по психосоматике. Москва: МИА; 2014. С. 101-14. [Smulevich AB. Lektsii po psikhosomatike [Lectures on psychosomatics]. Moskcow: MIA; 2014. P. 101-14.]

16. Kanner AM. Depression in neurological disorders. Lundbec Inst; 2005. 161 р.

17. Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996 Apr 27;347(9009): 1141-5.

18. Skoog I. The assotiation between midlife blood pressure levels and late–life cognitive function. Biomed Pharmacother. 1997;51(9):367-75.

19. Launer L, Masaki K, Petrovich H, et al. The association between midlife blood pressure level and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA. 1995 Dec 20;274(23):1846-51.

20. Ruitenberg A, Skoog I, Ott A, et al. Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord. 2001 JanFeb;12(1):33-9.

21. Kivipelto M, Ngandu T, Laatikainen T, et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006 Sep;5(9):735-41.

22. Старчина ЮА, Парфенов ВА, Чазова ИЕ и др. Когнитивные расстройства у пациентов с артериальной гипертензией. Журнал неврологии и психиатрии им. С.С.Корсакова. 2008;(4):19-23. [Starchina YuA, Parfenov VA, Chazova I, et al. Cognitive disorders in patients with arterial hypertension. Zhurnal nevrologii i psikhiatrii im. S.S.Korsakova. 2008;(4):19-23. (In Russ.)].

23. Парфенов ВА, Старчина ЮА. Когнитивные нарушения у пациентов с артериальной гипертензией – начальные проявления сосудистой патологии головного мозга. Неврология, нейропсихиатрия, психосоматика. 2011;3(1):27-33. [Parfenov VA, Starchina YuA. Cognitive disorders in patients with essential hypertension and their treatment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, neuropsychiatry, psychosomatics. 2011;3(1): 27-33. (In Russ.)]. DOI: http://dx.doi.org/10.14412/2074-2711-2011-130

24. Еремина ОВ. Когнитивные нарушения у больных артериальной гипертензией. Дисс. канд. мед. наук. 2007. 150 С. [Eremina OV. Kognitivnye narusheniya u bol'nykh arterial'noi gipertenziei. Diss. cand. med. sci. 2007. 150 P.]

25. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Аlzheimer’s disease. JAMA. 1997 Mar 12;277(10):813-7.

26. Мхитарян ЭА. Преображенская ИС. Болезнь Альцгеймера и цереброваскулярные расстройства. Неврологический журнал. 2006;(Приложение 1):4-12. [Mkhitaryan EA. Preobrazhenskaya IS. Alzheimer's disease and cerebrovascular disorders. Nevrologicheskii zhurnal. 2006;(S1):4-12. (In Russ.)].

27. Преображенская ИС, Яхно НН. Сосудистые когнитивные нарушения: клинические проявления, диагностика, лечение. Неврологический журнал. 2007;12(5):45-50. [Preobrazhenskaya IS, Yakhno NN. Vascular cognitive impairment: clinical manifestations, diagnosis, treatment. Nevrologicheskii zhurnal. 2007;12(5):45-50. (In Russ.)].

28. Яхно НН, Захаров ВВ, Локшина АБ. Синдром умеренных когнитивных нарушений при дисциркуляторной энцефалопатии. Журнал неврологии и психиатри им. С.С.Корсакова. 2005;105(2):13-7. [Yakhno NN, Zakharov VV, Lokshina AB. The syndrome of moderate cognitive disorders in dyscirculatory encephalopathy. Zhurnal nevrologii i psikhiatri im. S.S.Korsakova. 2005;105(2):13-7. (In Russ.)].

29. Яхно НН, Локшина АБ, Захаров ВВ. Лeгкие и умеренные когнитивные расстройства при дисциркуляторной энцефалопатии. Неврологический журнал. 2004;(2):30-5. [Yakhno NN, Lokshina AB, Zakharov VV. Light and moderate cognitive disorders in dyscirculatory encephalopathy. Nevrologicheskii zhurnal. 2004;(2):30-5. (In Russ.)].

30. Haag MD, Hofman A, Koudstaal PJ, et al. Duration of antihypertensive drug use and risk of dementia: a prospective cohort study. Neurology. 2009 May 19;72(20):1727-34. doi: 10.1212/01.wnl.0000345062.86148.3f. Epub 2009 Feb 18.

31. Perila R, White LR, Masaki K, et al. Reducing the risk of dementia: efficacy of long term treatment of hypertension. Stroke. 2006 May;37(5):1165-70. Epub 2006 Apr 6.

32. Guo Z, Fratiglioni L, Zhu L, et al. Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol. 1999 Aug;56(8):991-6.

33. Khachaturian AS, Zandi PP, Lyketos CG, et al. Antihypertensive medication use and incidence of Alzheimer’s disease: the Cache County Study. Arch Neurol. 2006 May;63(5):686-92. Epub 2006 Mar 13.

34. Qui C, von Strauss E, Fastbom J, et al. Low blood pressure and risk of dementia in the Kungholmen study: a 6 years follow-up study. Arch Neurol. 2003 Feb;60(2):223-8.

35. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised doubleblind placebo controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998 Oct 24; 352(9137):1347-51.

36. Tzourio C, Anderson C, Chapman N, et al. PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003 May 12;163(9):1069-75.

37. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertention. SHEP Cooperative Research group. JAMA. 1991 Jun 26;265(24):3255-64.

38. Diener HC, Sacco RL, Yusuf S, et al. Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) Study Group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a doubleblind, active and placebo controlled study. Lancet Neurol. 2008 Oct;7(10):875-84. doi: 10.1016/S1474-4422(08)70198-4. Epub 2008 Aug 29.

39. Lithell H, Hansson L, Skoog I, et al. SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003 May;21(5): 875-86.

40. Peters R, Beckett N, Forette F, et al. HYVET Investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 2008 Aug;7(8):683-9. doi: 10.1016/S1474-4422(08)70143-1. Epub 2008 Jul 7.

41. Yusuf S, Diener HC, Sacco RL, et al. PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008 Sep 18;359(12):1225-37. doi: 10.1056/NEJMoa0804593. Epub 2008 Aug 27.

42. Wilcock G, Mobius HJ, Stoffler A. on behalf of the MMM 500 group. A double blind placebo controlled multicentre study of memantine in mild to moderate vascular dementia. Int Clin Psychopharmacol. 2002 Nov;17(6):297-305.

43. Orgogzo JM, Rigaud AS, Stoffler A, et al. Efficacy and safety of memantine in patients with mild to moderate vascular dementia. A randomized placebo controlled trial (MMM 300 trial group). Stroke. 2002 Jul;33(7):1834-9.

44. Яхно НН, Преображенская ИС, Захаров ВВ, Мхитарян ЭА. Эффективность мемантина у пациентов с недементными когнитивными расстройствами. Результаты многоцентрового клинического наблюдения. Неврологический журнал. 2010; 15(2):52-8. [Yakhno NN, Preobrazhenskaya IS, Zakharov VV, Mkhitaryan EA. The efficacy of memantine in patients with non-dementive cognitive disorders. The results of the multicenter clinical observation. Nevrologicheskii zhurnal. 2010;15(2):52-8. (In Russ.)].

45. Левин ОС, Юнищенко НА, Дударова МА. Эффективность акатинола мемантина при умеренно выраженном когнитивном расстройстве. Журнал неврологии и психиатрии им. С.С. Корсакова. 2009;(7):36-42. [Levin OS, Yunishchenko NA, Dudarova MA. The effectiveness of akatinol memantine in patients with moderate cognitive disorder. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2009;(7):36-42. (In Russ.)].

46. Вознесенская ТГ. Эмоционально-аффективные и поведенческие нарушения при лeгких и умеренных когнитивных расстройствах. Опыт применения мемантина. Неврологический журнал. 2009;(3):49-55. [Voznesenskaya TG. Emotional-affective and behavioral disorders in mild and moderate cognitive impairment. The experience of memantine administration. Nevrologicheskii zhurnal. 2009;(3):49-55. (In Russ.)].


For citation:


Vakhnina N.V., Milovanova O.V., Grinyuk V.V. Neurological disorders in hypertensive patients. Neurology, Neuropsychiatry, Psychosomatics. 2015;7(4):57-64. (In Russ.) https://doi.org/10.14412/2074-2711-2015-4-57-64

Views: 545


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)